Association between apolipoprotein E polymorphism, lipids, and coronary artery disease in Tunisian type 2 diabetes

Journal of Clinical Lipidology

Volumn 2, Issue 5, 2008, Pages 360-364

  Chaaba, Raja ^a   Attia, Nebil ^a   Hammami, Sonia ^a   Smaoui, Maha ^a   Ben Hamda, Khaldoun ^a   Mahjoub, Sylvia ^a   Hammami, Mohamed ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Apolipoprotein E; Coronary artery disease; LDL cholesterol; Triglycerides; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; APOLIPOPROTEIN E; GLIBENCLAMIDE; HEPARIN; ISOSORBIDE DINITRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PROPRANOLOL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET THERAPY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; TUNISIA;

EID: 53249100285     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2008.08.441     Document Type: Article

References (28)

1. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
2. Das H.K., McPherson J., Bruns G.A.P., Karathanasis S.K., and Breslow J.L. Isolation, characterization and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem. 260 (1985) 6240-6247
3. Weisgraber K.H., Innerarity T.L., and Mahley R.W. Abnormal lipoprotein receptor-binding activity of the human E apolipoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 257 (1982) 2518-2521
4. Kataoka S., Robbins D.C., Cowman L.D., et al. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study. Arterioscler Thromb Vasc Biol. 16 (1996) 918-925
5. Wilson P.W., Schaefer E.J., Larson M.G., and Ordovas J.M. Apolipoprotein E alleles and risk of coronary disease: a meta-analysis. Arterioscler Thromb Vasc Biol. 16 (1996) 1250-1255
6. Frikke-Schmidt R., Nordestgaard B.G., Argerholm-Larsen B., Schnohr P., and Tybjærg-Hansen A. Context-dependent and invariant associations between lipids, lipoproteins and apolipoprotein E genotype. J Lipid Res. 41 (2000) 1812-1822
7. Jemaa R., Elasmi M., Naouali C., et al. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters. Clin Biochem. 39 (2006) 816-820
8. Morbois-Trabut L., Chabrolle C., Garrigue M.A., Lasfargues G., and Lecomte P. Apolipoprotein E genotype and plasma lipid levels in Caucasian diabetic patients. Diabetes Metab. 32 (2006) 270-227
9. Kharrazi H., Vaisi Raygani A., Sabokroh A.R., and Pourmotabbed T. Association between apolipoprotein E polymorphism and coronary artery disease in the Kermanshah population in Iran. Clin Biochem. 39 (2006) 613-616
10. Deiana L., Pes G.M., Carru C., et al. Lack of influence of apolipoprotein E4 on lipoprotein levels in the island population of Sardinia. Eur J Clin Invest. 28 (1998) 290-294
11. Kalina A., Szalai C., Prohaszka, Reiber I., and Csaszar A. Association of plasma lipid levels with apolipoprotein E polymorphism in type 2 diabetes. Diabetes Res Clin Pract. 56 (2002) 63-68
12. Kolovou G.D., and Anagnostopoulou K.K. Apolipoprotein E polymorphism, age and coronary heart disease. Age Res Rev. 6 (2007) 94-108
13. Hayden J.M., and Reaven P.D. Cardiovascular disease in diabetes mellitus type II: a potential role for novel cardiovascular risk factors. Curr Opin Lipidol. 11 (2000) 519-528
14. Chaaba R., Hammami S., Attia N., et al. Association of plasma cholesteryl ester transfer protein activity and polymorphism with coronary artery disease extent in Tunisian type II diabetic patients. Clin Biochem. 38 (2005) 373-378
15. Chaaba R., Attia N., Hammami S., et al. Association of SNP3 polymorphism in the apolipoprotein A-V gene with plasma triglyceride level in Tunisian type 2 diabetes. Lipids Health Dis. 4 (2005) 1-6
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
17. Smaoui M., Hammami S., Chaaba R., et al. Lipids and lipoprotein(a) concentrations in Tunisian type II diabetic patients. Relationship to glycemic control and coronary heart disease. J Diabetes Complications 18 (2004) 258-263
18. Hixon J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 31 (1990) 545-548
19. Nguyet Thu N., Tuyet Mai T.T., Ohmori R., et al. Apolipoprotein E polymorphism in Vietnamese children and its relationship to plasma lipid and lipoprotein levels. Metabolism 53 (2004) 1517-1521
20. Boemi M., Sirolla C., Testa R., et al. Apolipoprotein E polymorphisms and mortality in Italian type 2 diabetic patients. Eur J Clin Invest. 33 (2003) 296-300
21. Gómez-Coronado D., Álvarez J.J., Entrala A., Olmos J.A., Herrera E., and Lasunción M.A. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins. Atherosclerosis 147 (1999) 167-176
22. Fumeron F., Betoulle D., Luc G., et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infraction. J Clin Invest. 96 (1995) 1664-1697
23. Frikke-Schmidt R. Context-dependant and invariant associations between Apo E genotypes and levels of lipoproteins and risk of ischemic heart disease: a review. Scand J Clin Lab Invest Suppl. 233 (2000) 3-25
24. Luc G., Bard J.M., Arveiler D., et al. Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction: the ECTIM study. Arterioscler Thromb. 14 (1994) 1412-1419
25. Tan C.E., Tai E.S., Tan C.S., et al. Apo E polymorphism and lipid profile in three ethnic groups in the Singapore population. Atherosclerosis 170 (2003) 253-260
26. Djousse L., Pankow J.S., Arnett D.K., Eckfeldt J.H., Myers R.H., and Ellison R.C. Apolipoprotein E polymorphism modifies the alcohol-HDL association observed in the National Heart, Lung and Blood Institute Family Heart Study. Am J Clin Nutr. 80 (2004) 1639-1644
27. Sorlí J.V., Corella D., Francés F., et al. The effect of the APOE polymorphism on HDL-C concentrations depends on the cholesteryl ester transfer protein gene variation in a Southern European population. Clin Chim Acta. 366 (2006) 196-203
28. Lahoz C., Schaefer E.J., Cupples L.A., et al. Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study. Atherosclerosis 154 (2001) 529-537